XML Financial LLC raised its stake in Novartis AG (NYSE:NVS – Get Rating) by 1.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,989 shares of the company’s stock after buying an additional 200 shares during the period. XML Financial LLC’s holdings in Novartis […]
Argonautica Private Wealth Management Inc. acquired a new stake in Novartis AG (NYSE:NVS – Get Rating) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 3,214 shares of the company’s stock, valued at approximately $292,000. A number of other hedge funds have also bought and sold shares of […]
StockNews.com initiated coverage on shares of Novartis (NYSE:NVS – Get Rating) in a research note published on Thursday. The brokerage issued a strong-buy rating on the stock. Several other research firms have also issued reports on NVS. Citigroup lowered Novartis from a buy rating to a neutral rating in a report on Thursday, January 26th. […]
FDx Advisors Inc. lessened its holdings in Novartis AG (NYSE:NVS – Get Rating) by 1.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 57,787 shares of the company’s stock after selling 936 shares during the quarter. FDx Advisors Inc.’s holdings in Novartis were worth $5,242,000 as of its most recent SEC filing. Several […]
First Trust Advisors LP cut its stake in Novartis AG (NYSE:NVS – Get Rating) by 10.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 793,380 shares of the company’s stock after selling 88,494 shares during the period. First Trust Advisors […]